US President Donald Trump on Monday, 20 October 2025, signed an executive order directing the creation of a dedicated women's health division within the National Institutes of Health (NIH) and a White House Women's Health Task Force to accelerate research into diseases disproportionately affecting women. The signing ceremony, held at the White House, was attended by First Lady Melania Trump, Indian-American NIH Director Jay Bhattacharya, and other senior officials.

What the Executive Order Establishes

The order, formally titled 'Advancing Women's Health to Improve Outcomes in All Phases of Life', mandates the Department of Health and Human Services (HHS) to set up the new NIH division focused on conditions that have historically received insufficient research funding. The White House Women's Health Task Force will coordinate efforts across federal agencies, with Health and Human Services Secretary Robert F. Kennedy Jr. appointed to lead it. The task force held its inaugural meeting later the same day.

What Trump and Melania Said

Addressing the gathering, Trump acknowledged the research gap in women's medicine. 'Despite amazing advances in medical science, many diseases and conditions that disproportionately affect women remain chronically understudied,' he said. He credited Melania Trump with developing the initiative, calling the effort a priority for his administration. Melania outlined five priorities for the programme: directing research funding towards diseases that uniquely affect women; leveraging artificial intelligence to deepen understanding of female biology; accelerating the transition of promising therapies from laboratories to patients; ensuring medical advances remain affordable regardless of financial circumstances; and encouraging more open public discussion of women's health issues. 'Beginning today, we will change the reality of women's health,' the First Lady said.

Key Figures at the Ceremony

The announcement drew a notable roster of attendees. NIH Director Jay Bhattacharya, an Indian-American physician and academic, was acknowledged by Trump during his remarks and thanked for his work at the NIH. Also present were Second Lady Usha Vance, who attended with her infant child, and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. White House Chief of Staff Susie Wiles was recognised during the event; Trump referenced her personal experience as a breast cancer survivor.

Timing and Broader Context

The signing coincided with Breast Cancer Awareness Month, observed every October, lending symbolic weight to the announcement. The NIH is the primary biomedical research agency of the United States and already supports work on reproductive health and sex-related differences in disease — yet critics have long argued that women's conditions remain underfunded relative to their disease burden. This initiative represents the most significant executive-level commitment to women's health research at the federal level in recent years, though independent health-policy experts note that the scale of impact will depend on how Congress funds the new division and how robustly the task force coordinates across agencies.

What Comes Next

With the task force's first meeting already completed, the immediate focus shifts to translating the order's directives into funding allocations and research priorities at the NIH. Observers will watch whether the new division receives a dedicated budget line in the next federal appropriations cycle and how quickly the AI-driven research agenda Melania described moves from aspiration to active programmes.